Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
GH Analyst Ratings
Strong Buy
19 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GH Stock 12 Month Forecast
Average Price Target
$60.24
▲(48.30%Upside)
| Highest Price Target$70.00 | Average Price Target$60.24 | Lowest Price Target$52.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$40
Hold
-1.53%
Downside
Reiterated
05/31/25
Guardant Health's overall stock score is driven by its strong revenue growth and positive earnings call sentiment, which are offset by significant financial challenges, including high leverage, negative equity, and ongoing cash flow issues. The technical outlook is neutral, with potential resistance in the near term, while valuation concerns persist due to negative profitability. These factors collectively suggest cautious optimism, with improvements needed in financial health for a more favorable outlook.
Craig-Hallum
―
Buy
―
Reiterated
05/30/25
Bank of America Securities
$60
Buy
47.71%
Upside
Reiterated
05/16/25
Piper Sandler
$50→$60
Buy
47.71%
Upside
Reiterated
05/06/25
Scotiabank
$52→$57
Buy
40.32%
Upside
Reiterated
05/05/25
UBS
$65→$70
Buy
72.33%
Upside
Reiterated
05/01/25
TD Cowen
$56→$60
Buy
47.71%
Upside
Reiterated
05/01/25
J.P. Morgan
$55→$60
Buy
47.71%
Upside
Reiterated
05/01/25
William Blair
―
Buy
―
Reiterated
05/01/25
Guggenheim
$56
Buy
37.86%
Upside
Reiterated
05/01/25
BTIG
$60→$65
Buy
60.02%
Upside
Reiterated
05/01/25
Stifel Nicolaus
$53→$60
Buy
47.71%
Upside
Reiterated
05/01/25
Barclays
$55→$60
Buy
47.71%
Upside
Reiterated
05/01/25
Leerink Partners
$65
Buy
60.02%
Upside
Reiterated
05/01/25
Canaccord Genuity
$60→$65
Buy
60.02%
Upside
Reiterated
04/30/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$40
Hold
-1.53%
Downside
Reiterated
05/31/25
Guardant Health's overall stock score is driven by its strong revenue growth and positive earnings call sentiment, which are offset by significant financial challenges, including high leverage, negative equity, and ongoing cash flow issues. The technical outlook is neutral, with potential resistance in the near term, while valuation concerns persist due to negative profitability. These factors collectively suggest cautious optimism, with improvements needed in financial health for a more favorable outlook.
Craig-Hallum
―
Buy
―
Reiterated
05/30/25
Bank of America Securities
$60
Buy
47.71%
Upside
Reiterated
05/16/25
Piper Sandler
$50→$60
Buy
47.71%
Upside
Reiterated
05/06/25
Scotiabank
$52→$57
Buy
40.32%
Upside
Reiterated
05/05/25
UBS
$65→$70
Buy
72.33%
Upside
Reiterated
05/01/25
TD Cowen
$56→$60
Buy
47.71%
Upside
Reiterated
05/01/25
J.P. Morgan
$55→$60
Buy
47.71%
Upside
Reiterated
05/01/25
William Blair
―
Buy
―
Reiterated
05/01/25
Guggenheim
$56
Buy
37.86%
Upside
Reiterated
05/01/25
BTIG
$60→$65
Buy
60.02%
Upside
Reiterated
05/01/25
Stifel Nicolaus
$53→$60
Buy
47.71%
Upside
Reiterated
05/01/25
Barclays
$55→$60
Buy
47.71%
Upside
Reiterated
05/01/25
Leerink Partners
$65
Buy
60.02%
Upside
Reiterated
05/01/25
Canaccord Genuity
$60→$65
Buy
60.02%
Upside
Reiterated
04/30/25
Best Analysts Covering Guardant Health
1 Month
xxx
Success Rate
15/28 ratings generated profit
Average Return
+1.80%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.57% of your transactions generating a profit, with an average return of +1.80% per trade.
3 Months
xxx
Success Rate
8/15 ratings generated profit
Average Return
+9.11%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 53.33% of your transactions generating a profit, with an average return of +9.11% per trade.
1 Year
Success Rate
10/15 ratings generated profit
Average Return
+33.25%
reiterated a buy rating 27 days ago
Copying David Westenberg's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +33.25% per trade.
2 Years
xxx
Success Rate
11/15 ratings generated profit
Average Return
+37.53%
reiterated a xxx
rating 27 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +37.53% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GH Analyst Recommendation Trends
Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
9
8
2
2
0
Buy
26
42
49
37
35
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
35
50
51
39
35
Each month's total comprises the sum of three months' worth of ratings.
GH Financial Forecast
GH Stock Forecast FAQ
What is GH’s average 12-month price target, according to analysts?
Based on analyst ratings, Guardant Health’s 12-month average price target is 60.24.
What is GH’s upside potential, based on the analysts’ average price target?
Guardant Health has 48.30% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GH a Buy, Sell or Hold?
Guardant Health has a consensus rating of Strong Buy which is based on 19 buy ratings, 0 hold ratings and 0 sell ratings.
What is Guardant Health’s price target?
The average price target for Guardant Health is 60.24. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $70.00 ,the lowest forecast is $52.00. The average price target represents 48.30% Increase from the current price of $40.62.
The highest analyst price target is $70.00 ,the lowest forecast is $52.00. The average price target represents 48.30% Increase from the current price of $40.62.
What do analysts say about Guardant Health?
Guardant Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.
How can I buy shares of GH?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.